Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Weight Loss

Millions of people are losing weight using GLP-1s. How do the drugs affect their love lives?

Prescribing doctors often warn of the medications’ potential side-effects – but unexpected impacts on romantic relationships are less understood

The Guardian - AU

10 Cancer Warning Signs Oncologists Say Shouldn’t Be Ignored

Most people experience aches, fatigue, or digestive issues from time to time, and in most cases those symptoms have harmless explanations. However, oncologists consistently emphasize that persistent or unexplained changes deserve medical attention rather than being brushed aside. Early detection remains one of the biggest factors influencing successful cancer treatment,…

Budget and the Bees

Large BMJ Study Confirms GLP-1 Drugs Like Ozempic and Mounjaro Are Linked to a Real Hair Loss Risk

A new BMJ study links Ozempic and Mounjaro to 37–68% higher hair loss risk. The FDA is evaluating a safety signal. What patients need to know before their next dose.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

‘Ozempic face’ and hair loss: what evidence is there for weight-loss drug side-effects?

Research into GLP-1 medications is not always robust but complaints such as digestive problems are well known

The Guardian - UK

Millions of Older Americans Are Starting GLP-1 Drugs Under Medicare Without Age-Specific Safety Standards, Experts Say

The Medicare GLP-1 Bridge Program lacks required muscle, bone, and nutrition screening for adults over 65. Geriatric experts say older patients need different standards. Here's why.

Medical Daily

Millions of Older Americans Are Starting GLP-1 Drugs Under Medicare Without Age-Specific Safety Standards, Experts Say

The Medicare GLP-1 Bridge Program lacks required muscle, bone, and nutrition screening for adults over 65. Geriatric experts say older patients need different standards. Here's why.

Medical Daily

GLP-1 Weight-Loss Drugs May Be Thinning Bone: Doctors Are Starting to Have This Conversation with Patients

A July 2026 JCEM study found semaglutide and tirzepatide linked to greater hip bone loss, especially in people without diabetes. Here's what GLP-1 patients need to know now.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

Doctors Sound Alarm as Popular Weight Loss Drugs Wegovy and Mounjaro Are Linked to Sudden Hair Loss

Wegovy and Mounjaro are linked to a higher risk of hair loss in a major study, with researchers pointing to rapid weight loss and possible iron, zinc and biotin deficiencies.

International Business Times UK

The New Drug Melting Body Fat From 38% To 22% — And The Side Effect Patients Are Ignoring

A new weight loss drug is drawing serious attention from the medical community, and the comparisons to Ozempic are coming quickly. But researchers are pointing to one difference between the two that is proving difficult to overlook, and it may change how the conversation around weight loss medication develops from…

Bored Panda

Medicare's New GLP-1 Weight Loss Drug Program Launched July 1, but It Expires in 2027 with No Successor in Place

The Medicare GLP-1 Bridge launched July 1, 2026 at $50/month for eligible beneficiaries. It expires December 31, 2027, with the permanent BALANCE replacement indefinitely delayed.

Medical Daily

The First Oral GLP-1 Weight Loss Pill With No Food or Injection Requirements Is Now Available

Eli Lilly's Foundayo (orforglipron) is the first oral GLP-1 obesity pill with no food or water restrictions. FDA approved it April 1, 2026. Here is what patients should know.

Medical Daily

Man Loses 110 Lbs And Joins A Chinese Fat Camp, Says The Most Powerful Part Was Not The Weight

Weight loss content is everywhere. Before and afters, transformation reels, supplement ads disguised as testimonials- the internet is absolutely saturated with it, and most of it follows the same formula. But every now and then someone comes along with a story that cuts through all of that noise because it…

Bored Panda

'What's Going on With Her?' Serena Williams' Knee Recovery Update Sparks Fan Concern Over Apparent Weight Loss

Serena Williams' latest knee recovery video reassured fans about her rehabilitation, but many instead questioned her apparent weight loss following her Wimbledon withdrawal.

International Business Times UK

Weight loss drugs tied to unexpected side effect, study finds

IN FULL

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Weight loss drugs linked to loss of hair in major new study

The study looked at 50,000 people on GLP-1 agonist drugs such as Wegovy and Mounjaro

The Independent UK

The workforce runs on ... weight loss drugs? Employees on GLP-1s are taking fewer sick days

More Americans than ever are taking GLP-1s

International Business Times UK

Meghan Trainor's 'Unrecognisable Look' After Dramatic Weight Loss Sparks Claims Her Fuller Face Suited Her Better

Meghan Trainor's 60-pound weight loss sparks online debate, but her trainer emphasises her focus on strength and motherhood, promoting long-term health over appearance.

The Independent UK

The unexpected link between weight loss drugs and alcohol-related hospital visits

IN FULL

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Two weight-loss drugmakers in legal battle over which is most effective in helping users shed pounds

Novo Nordisk claims Eli Lilly compared peak doses of Zepbound against outdated, lower doses of Wegovy to advertise a 50-pound weight loss versus 33 pounds

International Business Times

Novo Nordisk Says Eli Lilly Used Misleading Weight Loss Drug Advertising. It's Suing

The lawsuit, filed Tuesday, alleges that Eli Lilly violated federal and state false advertising laws by promoting "knowingly outdated clinical trial" results that compare both companies' drugs.

Medical Daily

GLP-1 Drugs Like Ozempic Carry Elevated Risks of Muscle Loss and Malnutrition in Adults Over 65

GLP-1 drugs carry higher muscle loss, malnutrition, and bone density risks in adults over 65 that younger users don't face. Here's what older patients and prescribers need to know.

Times Life

Depression Has 6 Physical Symptoms That Most Indians Mistake for Other Health Problems

Chronic Pain That Has No Obvious SourcePersistent back pain, headaches that cycle every few days, joint aches that don't track with any injury, these are among the most common physical presentations of depression, and among the most frequently dismissed. A 2017 review published in the Journal of Affective Disorders found…

MyLifeXP

Are You Drinking Too Much Black Coffee for Fat Loss?

Black coffee is one of the most popular pre-workout drinks, with many people believing it can speed up fat loss. But is drinking more coffee really the secret to burning more calories? The answer may surprise you. Experts say black coffee can support metabolism and fat utilisation, but only when…

Marie Claire

I'm a Cardiometabolic Expert: GLP-1s May Improve Inflammation and Heart Health—But There's More to the Story

There's nuance to this one.

The Economic Times

US obesity crisis: Not losing weight despite exercising? American Heart Association study reveals the surprising truth about your health beyond the scale, blood pressure and cholesterol

Weight loss tips: Regular exercise offers significant health benefits, even without substantial weight loss. Increasing physical activity alone may not lead to major weight reduction. Strength training is crucial for preserving muscle mass during weight loss efforts. Maintaining weight loss often requires more extensive physical activity weekly. Successful weight management…

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the American Heart Association

the US Food and Drug Administration

73 stories

American Heart Association

62 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.